May 5 (Reuters) – DaVita on Tuesday raised its forecast for annual adjusted profit after beating Wall Street estimates for first-quarter results, betting on steady demand for its kidney dialysis services.
Shares of the company were up over 3% in after-hours trading.
Here are some details:
• The company’s results indicate it has regained momentum after bearing the brunt of rising patient care and operating costs in recent quarters.
• DaVita provides dialysis services at outpatient clinics and at home for patients with chronic kidney failure.
• The Colorado-based company now expects its 2026 adjusted profit per share to be between $14.10 and $15.20, compared with its previous projection of $13.60 to $15.
• On an adjusted basis, it reported a profit of $2.87 per share for the quarter ended March 31, above analysts’ estimates of $2.32 per share, according to data compiled by LSEG.
• The company reported quarterly revenue of $3.42 billion, compared with analysts’ estimates of $3.36 billion.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Sahal Muhammed)
